Experiment 442354
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | ROWINKSY,EK:. (1993). THE CLINICAL STATUS OF TOPOTECAN, A NOVEL INHIBITOR OF TOPOISOMERASE I.. 11(S-1) |
| Amount utilized | |
| Compound isolated | |
| Disease | DISCUSSED IN THIS REVIEW ARTICLE ARE SEVERAL CLINICAL PHASE I TRIALS OF TOPOTECAN. THE MOST COMMON TOXICITES OBSERVED WERE NEUTROPENIA, MYELOSUPPRESSION AND ANEMIA. THROMBOCYTOPENIA ALSO OCCURRED IN SEVERAL TRIALS. THESE STUDIES WERE DONE ON PATIENTS WITH A VARIETY OF CANCERS. ALSO EXAMINED IN THIS ARTICLE ARE PHARMACOKINETIC STUDIES. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |